GMC No. 6073739
Consultant Psychiatrist
Member of the Royal College of Psychiatrists
General Medical Council (GMC) registered No 6073739
Affiliate of King's College London
Consultant Psychiatrist
Dr Chris Kalafatis is a Consultant Psychiatrist working in South London & Maudsley NHS Foundation Trust, one of the most prestigious mental health facilities in Europe. He is also an Affiliate of King's College London where he leads clinical research in Translational and Cognitive Psychiatry. Chris researches the diagnostics of neurodegeneration and leads on clinical trials in Dementia at the Institute of Psychiatry, Psychology & Neuroscience, part of King's College London.
Chris has developed clinical-academic NHS clinics with a focus on brain health and digital innovation at service level. He has developed the first virtual NHS Brain Health Clinic. He has developed a novel digital cognitive assessment that employs AI for early diagnosis, high-resolution monitoring at the individual and large-population level.
Dr Kalafatis has an interest in undiagnosed ADHD in adults which stems from his clinical work in the NHS and private medicine. People with various comorbidities who struggle with day-to-day tasks and have done so for years are often dismissed by clinicians who are not primed to recognise neurodiversity. As a result, these underdiagnosed, neurodiverse patients face discrimination in their working lives as they remain untreated and their concerns are unfairly normalised. Chris strives to support patients and his clinical approach focuses on the "two-experts" model where patient and clinician collaborate as experts towards the common goal of treatment and recovery.
Chris has been an early proponent of telemedicine and telepsychiatry and in the early 2010s he developed a framework for the use of virtual assessments in outpatient clinics in NHS psychiatric trusts and his work has received national and international praise. He has led numerous pharmaceutical trials in Dementia as part of King's College, lectured on digital diagnostics and the use of AI in older adults internationally. He has advised pharma in the topic of brain health and digital biomarkers. He has been running memory services for more than 15 years.
In addition to English, Dr Kalafatis can carry out assessments in Greek.
ADHD
ADHD in older adults